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ABSTRACT 
Objective: The purpose of this study was to formulate and optimize mucoadhesive microspheres of antihypertensive drug (valsartan) within ethyl 
cellulose as a carrier polymer and carbopol 934P as a mucoadhesive polymer for controlling the release of valsartan. 
Methods: The emulsion solvent evaporation technique was used for preparation of microspheres of valsartan and the Box-Behnken design was 
employed with thee independent variables that is amount of ethyl cellulose (X1) and amount of carbopol 934P (X2) and stirring speed (X3) and 
evaluate four dependent variables such as percentage mucoadhesion, Q1 h, t90% and drug entrapment efficiency. 
Results: The optimum conditions were found to be X1= 200 mg, X2= 107 mg and X3= 1200rpm. The optimized batch exhibited a high drug 
entrapment efficiency of 85.63±1.384%, percentage mucoadhesion was 66.76±0.986% and drug release was also sustained for more than 12 h.  
Conclusion: The analysis of variance showed a significant effect of independent variables. The scaning electron microscopy (SEM) analysis showed that 
the microspheres were spherical and free-flowing. The microspheres of valsartan were stable after thee month stability study at accelerated condition. 
Keywords: Mucoadhesive microspheres, Valsartan, Carbopol 934P, Ethylcellulose, Box-Behnken design 




Hypertension is one of the primary risk factors for heart disease and 
stroke, the leading causes of death due to its high prevalence all 
around the globe [1-4]. Approximately 7.5 million deaths worldwide 
occur due to hypertension and predicted to be increased to 1.56 
billion adults with high blood pressure in 2025 [5, 6]. 
A number of different types of anti-hypertensive agents used to control 
elevated blood pressure [7]. Valsartan, a non-peptide, specific 
competitive angiotensin II type 1 receptor antagonist is a drug of choice 
in cardiovascular disorders, particularly in hypertension [8, 9]. 
The oral route is most convenient for the delivery of different dosage 
form as compared with other routes [10]. The absorption of valsartan is 
high (tmax ≈ 2) through oral administration, but it has poor 
bioavailability (23%) due to slow absorption from the gastrointestinal 
tract. Therefore, improving its therapeutic efficacy through oral route 
alternative drug delivery systems and dosage forms is needed [11-13]. 
Various investigations have confirmed that a gastro-retentive 
mucoadhesive delivery system could remain in the gastric mucosa 
for a long period of time and it improves the bioavailability and 
reduce drug loss [14, 15]. Moreover, it could play an effective role in 
drug localization in the stomach [16, 17]. The high surface-to-
volume ratio of this dosage form could improve drug absorption and 
drug bioavailability [18, 19]. 
In this work, mucoadhesive microspheres of valsartan were 
prepared with carbopol 934P as mucoadhesive and ethyl cellulose 
as carrier polymer by using the emulsion solvent evaporation 
technique. A Box-Behnken design was employed to study the effect 
of independent variables (amount of ethyl cellulose, amount of 
carbopol 934P and stirring speed) of mucoadhesive microspheres of 
valsartan on the physicochemical characteristics (drug entrapment 
efficiency, Q1 h, t90% and mucoadhesion). 
MATERIALS AND METHODS 
Materials 
Valsartan was obtained from Macleods Pharmaceutical Ltd. Sarigam 
(Gujarat, India). Carbopol 934P was purchased from sigma Aldrich 
Pvt. Ltd. Ethylcellulose, light liquid paraffin, Span 80, Ethanol 95%, 
petroleum ether, and methanol were purchased from Loba Chemie 
Pvt. Ltd. Mumbai. Hydrochloric acid (HCl) was purchased from 
Thermo Fisher Scientific India Pvt. Ltd. Mumbai. All other chemicals 
were of analytical grade. 
Preparation of microspheres 
Mucoadhesive microspheres of valsartan were prepared with an 
emulsion solvent evaporation technique. Ethyl cellulose was dissolved in 
95% ethanol; carbopol 934P and valsartan powder were added in ethyl 
cellulose solution under magnetic stirring for 2 h. Then this suspension 
was dispersed dropwise in light liquid paraffin containing span 80 as 
surfactant with continuous stirring on Remi mechanical stirrer at 1000 
rpm. After 5 h of stirring, ethanol was evaporated gradually and 
microspheres were produced. Prepared microspheres were washed 
with petroleum ether, filtered, dried at room temperature for 24 h and 
then stored in the desiccators until used. 
Box-behnken optimization design 
The box-behnken design was employed for optimizing the 
microspheres of valsartan and investigating the correlation between 
the experimental factors and responses. 
The independent factors chosen in the Box-Behnken design were: 
the amount of ethyl cellulose (X1), amount of carbopol 934P (X2) and 
stirring speed (X3). The levels of the factors are selected according to 
the literature [20, 21]. Twelve batches of microspheres and thee 
center point batches were prepared according to this design. 
In order to elucidate the effect of preparation conditions on 
dependent variables such as encapsulation efficiency, Q1h, t90% and 
mucoadhesion, the Box-Behnken design was used with the three 
factors selected and their respective thee levels (low, medium and 
high). To evaluate the response variables, a second-order 
polynomial model was utilized:  
=0+11+22+33+1212+1313+2323+1112+2222+3
332…(Eq.1) 
 is the predicted response; 0 is model constant; 1, 2, and 3 are 
independent variables; 1, 2, and 3 are linear coefficients; 12, 13 
and 23 are cross-product coefficients; and 11, 22, and 33 are the 
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quadratic coefficients. The quality of fit of the polynomial model 
equation was expressed with the coefficient of determination *2 
[22]. The selection of independent and dependent variables and 
their levels are given in table 1. 
 
Table 1: Independent and dependent variables 
Independent variable Variable level 
Low (-1) Medium (0) High (1) 
Amount of ethyl cellulose(X1) 100 mg 150 mg 200 mg 









Y1= percent entrapment efficiency, Y2= Q1h (percent cumulative drug release at 1h), Y3 = t90%, Y4 = percent mucoadhesion 
 
Determination of percentage yield 
The production yields of mucoadhesive microspheres of all 
formulation batches were evaluated using the weight of the final dried 
product (W1) with respect to the initial total weight of the raw 
materials used for the preparation of microspheres (W2) and percent 
production yields according to the equation 2 cited below [23-25]. 
%yield = Total amount of dried microspheres (W1)
Total weight of raw material (W2) × 100. (Eq. 2) 
Determination of drug entrapment efficiency 
A precisely measured amount of mucoadhesive microspheres (50 mg) 
of valsartan was dissolved in methanol with stirring until complete 
dissolution. The solution was then filtered, an aliquot of the filtrate 
was appropriately diluted, and the content of valsartan was 
determined spectrophotometrically at 248 nm. The determinations 
were made in triplicate. The percent drug entrapment efficiency was 
determined according to the following equation [26-28]. 
% Entrapment efficiency = Practical drug loading
Theoretical drug loading × 100 … (Eq. 3) 
Determination of particle size of microspheres 
The microsphere was examined with an optical microscope and the 
size of the microspheres was calculated with a pre-calibrated ocular 
micrometer and stage micrometer. About 200-300 particles of each 
formulation were observed and counted [29-31]. 
In vitro release study 
An appropriate amount of Microspheres (50 mg) was taken in a muslin 
cloth. Dissolution was performed using USP type II apparatus at 
37±0.5˚C, rotational speed of 50 rpm in 900 ml of 0.1N HCL (pH 1.2) for 
12 h. Samples (5 ml) were withdrawn at fixed time intervals and equally 
(5 ml) replaced with fresh dissolution medium [32, 33], filtered, diluted 
suitably and analyzed spectrophotometrically at 249 nm. Concentrations 
were calculated using calibration curves developed in respective media. 
Taking into account, the loss of the drug in aliquot replaced, the 









… … … … … … … … (Eq. 4) 
Where, Ci = Corrected absorbance, Vs = Sample of dissolution media 
withdrawn, Vt = Total volume of dissolution media. 
Dissolution release profiles were plotted with percentage drug 
released at different time intervals. Q1 h percent cumulative drug 
release (% CDR) and the average value of t90% for all batches was 
calculated from the dissolution data. 
In vitro wash-off test 
Mucoadhesive property of Microspheres was evaluated by In vitro 
wash-off test. The rats were sacrificed by cervical dislocation. The 
abdomen was opened and the stomach excised [37]. A 1-cm by 1-cm 
piece of rat stomach mucosa was cut and tied on a glass slide (3-inch 
by 1-inch) with thead. Approximately 100 microspheres were spread 
onto the wet rinsed tissue specimen and hanging prepared slide onto 
the grooves of a USP tablet disintegrating test apparatus. After that, the 
apparatus was switched on and the tissue specimen was given up and 
down movements for 10 h in a beaker having simulated gastric fluid 
(pH 1.2). The microspheres left behind on the surface of the gastric 
mucosa were counted after 10 h and the % mucoadhesion was 
calculated by the formula shown in Equation 5 [38, 39]. 
Percent mucoadhesion = Weight of adhered microspheres
Weight of applied microspheres × 100 … (Eq. 5) 
Release kinetics and mechanism 
To determine the release mechanism and kinetics, optimized 
formulation was attempted to fit into different mathematical models 
like zero order, first order, Higuchi’s Hixon-Crownwell and 
Korsmeyer-Peppas models [40, 41]. 
 
Table 2: Experiment plan and observed responses of the model 
 Independent factors  Responses 
Batch 
No. 
Amount of ethyl 
cellulose (mg) 












V1 -1(100) 1(150) 0(1000)  56.18±1.12 34.76±0.83 498 74 
V 2 -1(100) 0(100) 1(1200)  57.54±0.25 25.34±1.02 538 67 
V 3 1(200) -1(50) 0(1000)  74.66±0.68 22.24±0.95 725 51 
V 4 1(200) 0(100) 1(1200)  87.32±2.32 18.72±0.79 745 64 
V 5 1(200) 0(100) -1(800)  78.86±1.62 26.86±0.13 636 65 
V 6 1(200) 1(150) 0(1000)  85.16±0.58 28.48±1.58 558 68 
V 7 -1(100) -1(50) 0(1000)  51.68±0.74 33.56±0.90 612 54 
V 8 0(150) -1(50) 1(1200)  62.54±3.62 23.26±1.03 716 52 
V 9 0(150) 1(150) -1(800)  60.65±1.23 32.85±0.30 538 72 
V 10 0(150) 1(150) 1(1200)  64.94±2.22 24.98±0.72 568 69 
V 11 0(150) 0(100) 0(1000)  56.38±0.26 25.26±1.14 547 62 
V 12 -1(100) 0(100) -1(800)  50.45±2.32 35.66±1.16 524 70 
V 13 0(150) 0(100) 0(1000)  58.76±2.47 23.64±1.07 556 60 
V 14 0(150) 0(100) 0(1000)  58.12±0.16 23.88±0.90 576 62 
V 15 0(150) -1(50) -1(800)  53.76±0.72 31.08±1.75 628 52 
*mean±SD, n = 3 
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Determination of surface morphology 
Scanning electron microscope (SEM) (JEOL JSM-6100 scanning 
microscope, Japan) was used to determine surface characteristics of 
microspheres. Sample of microspheres was mounted on a stub and 
coated with a layer of gold using a sputter coater (JFC-1100). The 
samples were scanned at 5kV and photomicrograph at different 
magnification ratio [42]. 
RESULTS AND DISCUSSION 
Optimization 
In the Box-Behnken design, a total 15 formulations were proposed 
by Design expert software for thee factors such as the amount of 
ethyl cellulose (X1), amount of carbopol 934P (X2) and stirring speed 
(X3), which were varied at thee different levels (−1, 0 and 1). The 
effects of independent variables (factors) on the drug entrapment 
efficiency (%), Q1 h (%), t90% and mucoadhesion (%) were examined 
as optimization response parameters in this study. Summarize of the 
experimental plan and observed responses were presented in table 
2 and the percent yield, particle size and shape of microspheres 
were shown in table 3. 
The polynomial equation for entrapment efficiency as follows, 
according to the model:  
Y1 =+57.75+13.77X1+3.04X2+3.58X3+1.50 X1 X2+0.3425 X1 X3-1.12 X2 
X3+8.62 X12+0.5483 X22+2.17 X32 
The F-value of 86.85 implies the model is significant (p<0.0001) 
(table 4). So the X1, X2, X3, X12and X32 are significant model terms. The 
‘Pred R-Squared’ of 0.9191 is in rational agreement with the ‘Adj R-
Squared’ of 0.9822. 
 
Table 3: Results of percentage yield, particle size and shape of microspheres 
Batch No. Percent yield Particle size* (um) Shape of microspheres 
V1 75.24 104.28±2.64 Spherical 
V 2 82.86 92.64±2.84 Spherical 
V 3 78.52 98.84±3.67 Spherical 
V 4 87.64 95.21±2.34 Spherical 
V 5 70.16 124.32±3.98 Spherical 
V 6 82.34 118.16±3.24 Spherical 
V 7 73.28 96.74±1.82 Spherical 
V 8 83.25 95.98±2.73 Spherical 
V 9 71.86 120.22±4.16 Spherical 
V 10 87.36 93.96±3.14 Spherical 
V 11 72.56 108.62±3.21 Spherical 
V 12 68.14 112.26±2.63 Spherical 
V 13 74.64 106.92±2.85 Spherical 
V 14 76.86 108.56±1.64 Spherical 
V 15 74.52 114.76±3.93 Spherical 
*mean±SD, n = 3 
 
Table 4: Analysis of variance calculated for responses 
Batch No. Entrapment efficiency Q1 h t90% Mucoadhesion 
Regression sum of square  1990.15 360.32 80885.92 807.48 
df 9 9 9 9 
Mean square 221.13 40.04 8987.32 89.72 
F-value 86.85 39.78 13.46 153.81 
p-value <0.0001 <0.0004 <0.0053 <0.0001 
Lack of fit sum of square 9.70 3.50 2898.75 0.2500 
df 3 3 3 3 
Mean square 3.23 1.17 966.25 0.0833 
F-value 2.13 1.53 4.39 0.0625 
Correlation coefficient (R2) 0.9936 0.9862 0.9604 0.9964 
 
The polynomial equation for Q1 h as follows, according to the model:  
Y1 =+24.26-4.13X1+1.37X2-4.27X3+1.37 X1 X2+0.5450 X1 X3-0.0125 X2 
X3+2.05 X12+3.45 X22+0.3337 X32 
The F-value of 39.78 implies the model is significant (p<0.0004) 
(table 4). So the X1, X2, X3, X12, X12 and X22 are significant model terms. 
The ‘Pred R-Squared’ of 0.8372 is in rational agreement with the ‘Adj 
R-Squared’ of 0.9614. 
The polynomial equation for t90% as follows, according to the model:  
Y1 =+559.67+61.50X1-64.88X2+30.13X3-13.25 X1 X2+23.75 X1 X3-
14.50X2 X3+18.42 X12+20.17 X22+32.67 X32 
The F-value of 13.46 implies the model is significant (p<0.0053) 
(table 4). So the X1, X2 and X3 are significant model terms. The ‘Pred 
R-Squared’ of 0.4376 is in rational agreement with the ‘Adj R-
Squared’ of 0.8890. 
The polynomial equation for mucoadhesion as follows, according to 
the model:  
Y1 =+61.33-2.13X1+9.25X2-0.8750X3-0.7500 X1 X2+0.5000 X1 X3-
0.7500X2 X3+2.83 X12-2.42 X22+2.33 X32 
The F-value of 153.81 implies the model is significant (p<0.0053) 
(table 4). So the X1, X2, X3, X12, X22 and X32 are significant model terms. 
The ‘Pred R-Squared’ of 0.9877 is in rational agreement with the ‘Adj 
R-Squared’ of 0.9890. 
Coefficients with more than one-factor term represent interaction 
terms and those with second order terms represent quadratic 
relationships. The coefficient’s sign shows how independent factors 
influence the responses. The positive sign of the coefficient indicates 
the response increases (synergistic effect), and a negative sign 
indicates the response decreases (antagonist effect). 
For all these formulations proposed by the Box-Behnken design, the 
results of examining responses (entrapment efficiency, Q1 h, t90% and 
mucoadhesion) were found within the limits. The actual and 
predicted responses for all response variables investigated in this 
study with the parentage of errors in prognosis are given in table 5. 
Lal et al. 
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Table 5: Actual and predicted responses of all response variables 
Batch No. Entrapment efficiency Q1 h (%CDR) T90% Percent mucoadhesion 
Actual Pred. Actual Pred. Actual Pred. Actual Pred. 
V1 56.18 54.69 34.76 33.99 498.00 485.13 74.00 73.88 
V 2 57.54 58.01 25.34 25.96 538.00 555.63 67.00 67.25 
V 3 74.66 76.15 22.24 23.01 725.00 737.88 51.00 51.13 
V 4 87.32 86.23 18.72 18.79 745.00 726.13 64.00 64.00 
V 5 78.86 78.39 26.86 26.24 636.00 618.38 65.00 64.75 
V 6 85.16 85.22 28.48 28.26 558.00 581.63 68.00 68.13 
V 7 51.68 51.61 33.56 33.78 612.00 588.38 54.00 53.88 
V 8 62.54 62.14 23.26 22.42 716.00 722.00 52.00 51.88 
V 9 60.65 61.05 32.85 33.69 538.00 532.00 72.00 72.13 
V 10 64.94 65.96 24.98 25.13 568.00 563.25 69.00 68.88 
V 11 56.38 57.75 25.26 24.26 547.00 559.67 62.00 61.33 
V 12 50.45 51.54 35.66 35.59 524.00 542.88 70.00 70.00 
V 13 58.76 57.75 23.64 24.26 556.00 559.67 60.00 61.33 
V 14 58.12 57.75 23.88 24.26 576.00 559.67 62.00 61.33 
V 15 53.76 52.74 31.08 30.93 628.00 632.75 52.00 52.13 
 
Linear correlation plots between the actual and predicted response 
variables are given in fig. 1, and their corresponding residual plots 
showing the scatter of the residuals versus predicted values are 
given in fig. 2. 
 
 
Fig. 1: Linear correlation plots between the actual vs predicted. a)-entrapment efficiency, b)-Q1 h, c)-t90% and d)-mucoadhesion 
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Fig. 2: Showing the scatter of residues vs predicted a)-entrapment efficiency, b)-Q1 h, c)-t90% and d)-mucoadhesion 
 
Evaluating the main and interaction effects of the independent 
variables (factors), a three-dimensional response surface graph is 
very useful. The three-dimensional response surface graph relating 
drug entrapment efficiency (fig. 3) has shown that increase in drug 
entrapment with the increase in the amount of ethyl cellulose (X1), 
amount of carbopol 934P (X2) and stirring speed (X3). The three-
dimensional response surface graph relating Q1 h (fig. 4) indicates 
the increase in the amount of ethyl cellulose(X1) and stirring speed 
(X3) percent Q1 h is decreasing, however the amount of carbopol 
934P (X2) increases Q1 h and all the thee factors opposes the effect in 
case of t90% (fig. 5). In case of percent mucoadhesion (fig. 6), shown 
that increase the amount of carbopol 934P (X2) mucoadhesion is 
also increasing, however, increases the amount of ethyl cellulose 
(X1) and stirring speed (X3) the mucoadhesion is decreased. 
 
 
Fig. 3: Thee-dimensional response surface graphs related to drug entrapment efficiency 
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Fig. 4: Thee-dimensional response surface graphs related to Q1 h (%CDR) 
 
 
Fig. 5: Thee-dimensional response surface graphs related to t90% 
 
 
Fig. 6: Thee-dimensional response surface graphs related to mucoadhesion 
 
Percent yield and entrapment efficiency 
The results of percent yield are given in table 3. It is shown that all 
the coded batches varies from 68.14 to 87.64% the minimum 
percentage yield was 68.14% of batch V12 whereas maximum of 
87.64% of V4 batch. 
The entrapment efficiency of all batches was varied from 50.45 to 
87.32% shown in table 2. The maximum entrapment efficiency was 
87.32% of batch V4. It shows entrapment efficiency is increased due 
to an increase in the concentration of ethyl cellulose, carbopol 934P 
and increasing stirring speed. The entrapment efficiency is highly 
depending on the amount of ethylcellulose used, however other two 
factors such as the amount of carbopol 934P and stirring speed also 
increases entrapment efficiency, but in lesser extent as compared to 
the amount of ethyl cellulose. Similar results have been reported in 
the literature with other drugs [43, 44]. 
Particle size of microspheres 
The microspheres of all the batches are spherical and free-flowing 
and the size varies from 92.64 to 124.32um as shown in table 3. The 
size of the microspheres also depends on the concentration of 
polymer solution and stirring speed. The size of the microspheres 
was increased by increasing the amount of polymers [45, 46], but 
decreases with increasing the stirring speed. 
In vitro drug release study 
In vitro drug release study carried on all the coded formulations and 
Q1 h and t90% were calculated. The values of Q1 h of prepared 
formulations are 18.72 to 35.66% and t90% in the range of 498 to 745 
min as shown in table 2. The amount of ethyl cellulose and stirring 
speed inversely affects the Q1 h, although increasing the 
concentration of carbopol 934P, Q1 h is also increased. 
Batch V3 and V4  shows drug release for a long time and batch V1 and 
V12 shows 90% drug release in less than 525 min. It shows that by 
increasing the amount of ethyl cellulose and stirring speed the 
microspheres released drug for a long time while the amount of 
carbopol 934P reduced drug release. The result agrees with that of 
Patel J. et al. [21]. The drug release curves of all the batches were 
shown in fig. 7. 
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Fig. 7 Drug release profile of batches (a)-V1-V7 and (b)-V8-V15, mean±SD, n = 3 
 
Percent mucoadhesion 
In vitro wash-off test for percentage mucoadhesion of coded 
formulations were varied from 51 to 74%. Results of mucoadhesion 
indicated that the amount of ethyl cellulose and stirring speed had a 
negative effect on percent mucoadhesion. Mucoadhesion totally 
depends upon carbopol 934P because it is mucoadhesive polymer 
and the higher amount of polymer result in a greater amount of 
free–COOH (carboxyl group) [47] which are responsible for binding 
to the sialic acid group inside the mucous network that’s why batch 
V1 and V9 show maximum mucoadhesion as shown in table 2. 
Optimized formulation 
Post analysis of the software was used to determine the optimum 
values of the factors for maximum entrapment, minimum Q1 h, 
maximum t90% and maximum percent mucoadhesion. Finally, the 
optimum levels of amount of ethyl cellulose (X1 = 1), the amount of 
carbopol 934P (X2 = 0.123) and stirring speed (X3 = 1) were 
obtained. These values predict 86.65% entrapment efficiency, 
19.16% Q1 h, 715 min t90% and 64.91% mucoadhesion. 
After the confirmation of the optimum batch and their predicted 
responses, all values were validated by further conducting in vitro 
studies of mucoadhesive microspheres of valsartan and an average 
of 85.63% entrapment efficiency, 20.14% Q1 h, 730 min t90% and 
66.76% mucoadhesion. The predicted values and actual responses of 
the optimized formulation are shown in table 6 and the release 
profile is shown in fig. 8. 
To determine the mechanism of drug release from the optimized 
formulation, the release profile fitted to zero order, first order, Higuchi 
equation and Hixon-Crownwell, the ‘R2’ value was found to be 0.966, 
0.974, 0.987 and 0.991 respectively as shown in table 7. The release 
profile fitted to Korsmeyer-Peppas equation, the “R2” value was found 
to be 0.998 and “n” value was 0.633 for the optimized batch. It 
confirmed that the mechanism of drug release was the nonfickian 
diffusion, may be owing to the swelling of the microspheres. 
 
Table 6: Predicted values and actual responses of optimum formulation 
Response variables Predicted value Actual responses* 
Y1 = Entrapment efficiency 86.65 85.63±1.92 
Y2 = Q1h = % cumulative drug release after 1 h 19.16 20.32±0.63 
Y3 = t90% 715 730 
Y4 = Percent mucoadhesion 64.91 66.76 
*mean±SD, n = 3 
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Fig. 8: Release profile of optimized formulation, mean±SD, n = 3 
 
Table 7: Release kinetic data for the batch T1 
Batch No. Zero-order kinetics R2 First order kinetics R2 Higuchi kinetics R2 Hixon-crowell R2 Korsmeyer-peppas 
T1 0.966 0.974 0.987 0.991 0.998 0.633 
 
Surface morphology 
Scanning Electron Microscopic (SEM) analysis of the optimized 
batch (T1) revealed discrete and spherical microspheres. It appeared 
to have smooth surfaces at higher magnification as shown in fig. 9. 
Stability studies of optimized formulation (T1) 
The formulation stored for three months on 40±2 °C temperature 
and 75±5% relative humidity. It was found to be stable in between 
and after three months. The results are shown in table 8. 
 
 
Fig. 9: Scanning electron microscopic images of optimized formulation 
 
Table 8: Accelerated stability studies of optimized formulation 
Response Initial After 3 mo* 
Y1 = Entrapment efficiency 85.63±1.92 83.46±2.62 
Y2 = Q1h = % cumulative drug release after 1 h 20.32±0.63 22.04±2.86 
Y3 = t90% 732 724 
Y4 = Percent mucoadhesion 66.76 65.96 
*mean±SD, n = 3 
 
CONCLUSION 
The entrapment efficiency, Q1h, t90% and percent Mucoadhesion, 
analyzed though Box-Behnken design significantly affected by 
independent variables such as the amount of ethyl cellulose (X1), 
amount of carbopol 934P (X2) and stirring speed (X3). The optimized 
formulation exhibited drug release of the microspheres is more than 
12 h, indicates the microspheres have sustained release Moreover, it 
has shown high entrapment efficiency and good Mucoadhesion. 
Actual responses of the optimized batch have close proximity with 
the predicted value. SEM analysis revealed that the microspheres of 
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spherical in shape and free-flowing and the stability studies of 
optimum formulation proved that the optimum formulation is stable 
for a long period of time. All these studies show that the 
mucoadhesive microspheres of valsartan are excellent alternative 
over the conventional delivery system. 
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